Serum small RNAs in metastatic colorectal cancer predict response to chemotherapy and characterize high-risk patients.

Autor: Mjelle R; Department of Cancer and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Laboratoriesenteret 4. Etg Erling Skjalgssons Gate 1 7030, Trondheim, Norway. robin.mjelle@ntnu.no.; Department of Pathology, St.Olav's Hospital, Trondheim, Norway. robin.mjelle@ntnu.no., Kristensen AK; Department of Oncology, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway., Tora S Solheim; Department of Cancer and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Laboratoriesenteret 4. Etg Erling Skjalgssons Gate 1 7030, Trondheim, Norway.; Department of Oncology, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway., Westvik GS; Cancer Clinic, Levanger Hospital, Nord-Trøndelag Health Trust, Trondheim, Norway., Elvebakken H; Department of Oncology, Møre Og Romsdal Hospital Trust, Åsehaugen 5, 6017, Ålesund, Norway., Hofsli E; Department of Cancer and Molecular Medicine, NTNU, Norwegian University of Science and Technology, Laboratoriesenteret 4. Etg Erling Skjalgssons Gate 1 7030, Trondheim, Norway.; Department of Oncology, St. Olav's Hospital, Trondheim University Hospital, Trondheim, Norway.

Publikováno v: Molecular cancer [Mol Cancer] 2024 Jun 27; Vol. 23 (1), pp. 133. Date of Electronic Publication: 2024 Jun 27.

Do older patients with colorectal cancer experience more deterioration in health-related quality of life than younger patients during the first year of palliative chemotherapy? A prospective real-world observational study.

Autor: Hatlevoll I; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Oncology, St. Olav's Hospital, Trondheim, Norway. Electronic address: ingunn.hatlevoll@ntnu.no., Kristensen AK; Department of Oncology, St. Olav's Hospital, Trondheim, Norway., Solheim TS; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Oncology, St. Olav's Hospital, Trondheim, Norway., Elvebakken H; Department of Oncology, Ålesund Hospital, Møre og Romsdal Hospital Trust, Ålesund, Norway., Salvesen Ø; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Oldervoll LM; Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway; Center for Crisis Psychology, Faculty of Psychology, University of Bergen, Norway., Wibe A; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Surgery, St. Olav's Hospital, Trondheim, Norway., Hofsli E; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Oncology, St. Olav's Hospital, Trondheim, Norway.

Publikováno v: Journal of geriatric oncology [J Geriatr Oncol] 2024 Apr; Vol. 15 (3), pp. 101715. Date of Electronic Publication: 2024 Feb 15.

Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms.

Autor: Venizelos A; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Sorbye H; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Elvebakken H; Department of Oncology, Ålesund Hospital, Møre og Romsdal Hospital Trust, Ålesund, Norway.; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway., Perren A; Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland., Lothe IMB; Department of Pathology, Oslo University Hospital, Oslo, Norway., Couvelard A; Department of Pathology, Université Paris Cité and AP-HP, Bichat Hospital, Paris, France., Hjortland GO; Department of Oncology, Oslo University Hospital, Oslo, Norway., Sundlöv A; Departmentt of Oncology, Skåne University Hospital, Lund, Sweden.; Department of Medical Radiation Physics, Lund University, Lund, Sweden., Svensson J; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden., Garresori H; Department of Oncology, Stavanger University Hospital, Stavanger, Norway., Kersten C; Department of Research, Hospital of Southern Norway, Kristiansand, Norway., Hofsli E; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Oncology, St. Olavs Hospital, Trondheim, Norway., Detlefsen S; Department of Pathology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark., Vestermark LW; Department of Oncology, Odense University Hospital, Odense, Denmark., Ladekarl M; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.; Department of Oncology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark., Tabaksblat EM; Department of Oncology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark., Knappskog S; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway.

Publikováno v: Endocrine-related cancer [Endocr Relat Cancer] 2023 Aug 23; Vol. 30 (10). Date of Electronic Publication: 2023 Aug 23 (Print Publication: 2023).

Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine Carcinoma.

Autor: Knappskog S; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Grob T; Institute of Pathology, University of Bern, Bern, Switzerland., Venizelos A; K.G. Jebsen Center for Genome-Directed Cancer Therapy, Department of Clinical Science, University of Bergen, Bergen, Norway.; Department of Oncology, Haukeland University Hospital, Bergen, Norway., Amstutz U; Institute of Clinical Chemistry, Inselspital, Bern University Hospital, Bern, Switzerland., Hjortland GO; Department of Oncology, Oslo University Hospital, Oslo, Norway., Lothe IM; Department of Pathology, Oslo University Hospital, Oslo, Norway., Kersten C; Department of Research, Hospital of Southern Norway, Kristiansand, Norway., Hofsli E; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Oncology, St Olavs Hospital, Trondheim, Norway., Sundlöv A; Department of Oncology, Skåne University Hospital, Lund, Sweden.; Department of Medical Radiation Physics, Lund University, Lund, Sweden., Elvebakken H; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Oncology, Ålesund Hospital, Møre og Romsdal Hospital Trust, Ålesund, Norway., Garresori H; Department of Oncology, Stavanger University Hospital, Stavanger, Norway., Couvelard A; Department of Pathology, Université Paris Cité and AP-HP, Bichat Hospital, Paris, France., Svensson J; Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden., Sorbye H; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway., Perren A; Institute of Clinical Chemistry, Inselspital, Bern University Hospital, Bern, Switzerland.

Publikováno v: JCO precision oncology [JCO Precis Oncol] 2023 Feb; Vol. 7, pp. e2200336.

1100MO Molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms

Autor: Sorbye, H., Venizelos, A., Elvebakken, H., Perren, A., Lothe, I.M.B., Hjortland, G.O., Sundlov, A., Svensson, J., Garresori, H., Kersten, C., Krogh, M., Detlefsen, S., Knappskog, S.

Publikováno v: In Annals of Oncology September 2021 32 Supplement 5:S910-S911